Search | Influenza A(H1N1)

  • BIREME | OPAS | OMS logo

Search history  ()

Refine your search

Collapse All  Hide all
Expand All  Show all
Thematic areas
Fulltext (1)

Send by email

You have 0 documents selected.

No documents was selected

Results  1-1 de 1

Availability of a new candidate reassortant vaccine virus for pandemic (H1N1) 2009 virus vaccine development: NIBRG-121xp

Author(s): World Health Organization - WHO
Source: s.l; World Health Organization; Aug. 6, 2009. 2 p.
Repository Complementary ID: 264
Abstract: A new candidate reassortant vaccine virus (NIBRG-121xp) has been developed by extended egg passage of the reverse genetics technology derived reassortant NIBRG-121 originally developed from an A/California/7/2009(H1N1)v virus by the National Institute for Biological Standards and Control (NIBSC), Potters Bar, Hertfordshire, United Kingdom.
Results  1-1 de 1